(NASDAQ: BMEA) Biomea Fusion's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.22%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.
Biomea Fusion's earnings in 2025 is -$112,091,000.On average, 4 Wall Street analysts forecast BMEA's earnings for 2025 to be -$97,742,741, with the lowest BMEA earnings forecast at -$118,421,951, and the highest BMEA earnings forecast at -$80,336,499. On average, 4 Wall Street analysts forecast BMEA's earnings for 2026 to be -$89,114,006, with the lowest BMEA earnings forecast at -$144,010,614, and the highest BMEA earnings forecast at -$59,508,518.
In 2027, BMEA is forecast to generate -$65,756,912 in earnings, with the lowest earnings forecast at -$94,023,458 and the highest earnings forecast at -$37,490,366.